# FDA recall D-269-2013

> **Mylan Pharmaceuticals Inc.** · Class III · drug recall initiated 2013-02-26.

## Product

Lisinopril Tablets, USP 10 mg, Rx only, 1000 count bottles,  Manufactured for: Mylan Pharmaceuticals Inc ,Morgantown, WV 26505 U.S.A. Made in India; NDC 0378-20740-10

## Reason for recall

Tablets/Capsules Imprinted With Wrong ID: Pharmaceuticals are imprinted with an incorrect identifier code on the embossed tablets..

## Distribution

Nationwide.

## Key facts

- **Recall number:** D-269-2013
- **Recalling firm:** Mylan Pharmaceuticals Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-26
- **Report date:** 2013-05-01
- **Termination date:** 2013-12-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Morgantown, WV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-269-2013

## Citation

> AI Analytics. FDA recall D-269-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-269-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*